M<sub>3</sub> subtype of muscarinic acetylcholine receptor inhibits cardiac fibrosis via targeting microRNA-29b/beta-site app cleaving enzyme 1 axis.

Authors:
Li W; Yu J; Yang Y; Wang J; Liu Y and 4 more

Journal:
Cardiovasc Diagn Ther

Publication Year: 2024

DOI:
10.21037/cdt-23-309

PMCID:
PMC10904290

PMID:
38434562

Journal Information

Full Title: Cardiovasc Diagn Ther

Abbreviation: Cardiovasc Diagn Ther

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Cardiac & Cardiovascular Systems

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://cdt.amegroups.com/article/view/10.21037/cdt-23-309/coif). All authors report that this work was supported by National Natural Science Foundation of China. The authors have no other conflicts of interest to declare."

Evidence found in paper:

"Funding: This work was supported by the National Natural Science Foundation of China (Nos. 81673424, 82073838 and 82273917)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025